SiRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Kandimalla, Ramesh J L ^a   Wani, Willayat ^a   Bk, Binukumar ^a   Gill, Kiran ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

A 42; Alzheimer's Disease; IMR 32 Cells; presenilins; siRNA

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; NICASTRIN; PEPTIDES AND PROTEINS; PRESENILIN 1; PROTEIN PEN 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; SECRETASE;

ARTICLE; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; BLOTTING, WESTERN; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; MICROSCOPY, FLUORESCENCE; PRESENILIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84855213321     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-2     Document Type: Article

References (27)

1. A century of Alzheimer's disease. Goedert M, Spillantini MG, Science 2006 314 777 781 10.1126/science.1132814 17082447 (Pubitemid 44706636)
2. The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. Cole SL, Vassar R, J Biol Chem 2008 283 29621 29625 10.1074/jbc.R800015200 18650431
3. A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Weidemann A, Eggert S, Reinhard FB, Vogel M, Paliga K, Baier G, Masters CL, Beyreuther K, Evin G, Biochemistry 2002 4 12825 2835
4. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Tanzi RE, Bertram L, Cell 2005 120 545 555 10.1016/j.cell.2005.02. 008 15734686 (Pubitemid 40269768)
5. The Alzheimer family of diseases: many etiologies, one pathogenesis? Hardy J, Proc Natl Acad Sci USA 1997 94 2095 2097 10.1073/pnas.94.6.2095 9122152 (Pubitemid 27136831)
6. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F, Nature 1998 391 387 390 10.1038/34910 9450754 (Pubitemid 28093512)
7. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease. Wolfe MS, Xia W, Moore CL, Leatherwood DD, Ostazewski B, Rahmati T, Donkor IO, Selkoe DJ, Biochemistry 1999 38 4720 4727 10.1021/bi982562p 10200159 (Pubitemid 29183966)
8. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ, Nature 1999 398 513 517 10.1038/19077 10206644 (Pubitemid 29177490)
9. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH, Price DL, Borchelt DR, Sisodia SS, J Biol Chem 1997 272 28415 28422 10.1074/jbc.272.45.28415 9353300 (Pubitemid 27517788)
10. Endoproteolytic processing and stabilization of wild-type and mutant presenilin. Ratovitski T, Slunt HH, Thinakaran G, Price DL, Sisodia SS, Borchelt DR, J Biol Chem 1997 272 24536 24541 10.1074/jbc.272.39.24536 9305918 (Pubitemid 27418666)
11. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. Yu G, Chen F, Levesque G, Nishimura M, Zhang DM, Levesque L, Rogaeva E, Xu D, Liang Y, Duthie M, St George-Hyslop PH, Fraser PE, J Biol Chem 1998 273 16470 16475 10.1074/jbc.273.26.16470 9632714 (Pubitemid 28311430)
12. Co-expressed presenilin 1 NTF and CTF form functional gamma-secretase complexes in cells devoid of full-length protein. Laudon H, Mathews PM, Karlstrom H, Bergman A, Farmery MR, Nixon RA, Winblad B, Gandy SE, Lendahl U, Lundkvist J, Naslund J, J Neuro Chem 2004 89 44 53 (Pubitemid 38420673)
13. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio-Mower J, Harrison T, Lellis C, Nadin A, Neduvelil JG, Register RB, Sardana MK, Shearman MS, Smith AL, Shi XP, Yin KC, Shafer JA, Gardell SJ, Nature 2000 405 689 694 10.1038/35015085 10864326 (Pubitemid 30428655)
14. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, Tsai JY, Rahmati T, Xia W, Selkoe DJ, Wolfe MS, Nat Cell Biol 2000 2 428 434 10.1038/35017062 10878808
15. Gamma-Secretase in biology and medicine. Wolfe MS, Semin Cell Dev Biol 2009 20 219 224 10.1016/j.semcdb.2008.12.011 19162210
16. RNA interference: biology, mechanism, and applications. Microbiol. Agarwal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK, Mol Biol Rev 2003 67 657 685 10.1128/MMBR.67.4.657-685.2003 (Pubitemid 37549773)
17. Allele-specific silencing of dominant disease genes. Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL, Paulson HL, Proc Natl Acad Sci USA 2003 100 7195 7200 10.1073/pnas.1231012100 12782788 (Pubitemid 36706415)
18. Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Miller VM, Gouvion CM, Davidson BL, Paulson HL, Nucleic Acids Res 2004 32 661 668 10.1093/nar/gkh208 14754988 (Pubitemid 38263057)
19. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R, Nature 1999 398 518 522 10.1038/19083 10206645 (Pubitemid 29177491)
20. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, Serneels L, Umans L, Schrijvers V, Checler F, Vanderstichele H, Baekelandt V, Dressel R, Cupers P, Huylebroeck D, Zwijsen A, Van Leuven F, De Strooper B, Proc Natl Acad Sci USA 1999 96 11872 11877 10.1073/pnas.96.21.11872 10518543 (Pubitemid 29502825)
21. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J, Selkoe DJ, Science 2002 297 353 356 10.1126/science.1072994 12130773 (Pubitemid 34790756)
22. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME, Nature 1999 402 533 537 10.1038/990107 10591213
23. Amyloid, the presenilins and Alzheimer's disease. Hardy J, Trends Neuro sci 1997 20 154 159 10.1016/S0166-2236(96)01030-2 (Pubitemid 27116286)
24. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Scheuner D, Eckkman C, Jensen M, Song X, Citron M, Suzuki N, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S, Nat Med 1996 2 864 870 10.1038/nm0896-864 8705854 (Pubitemid 26296755)
25. Prostate apoptosis response-4 enhances secretion of amyloid beta peptide 1-42 in human neuroblastoma IMR-32 cells by a caspase-dependent pathway. Guo Q, Xie J, Chang X, Du H, J Biol Chem 2001 276 16040 16044 10.1074/jbc.M010996200 11278808
26. Presenilins as therapeutic targets for the treatment of Alzheimer's disease. Golde TE, Younkin SG, Trends Mol Med 2001 7 264 269 10.1016/S1471-4914(01)02064-0 11378516 (Pubitemid 32545523)
27. A substrate based difluoro ketone selectivity inhibits Alzheimer's gamma-secretase activity. Wolfe MS, Citron M, Diehl TS, Xia W, Donkor IO, Selkoe DJ, J Med Chem 1998 41 6 9 10.1021/jm970621b 9438016 (Pubitemid 28070461)